Skip to main content
Clinical Trials/NCT05751889
NCT05751889
Recruiting
Not Applicable

Reducing the Risk of Viral Hepatitis C and Other Sexually Transmitted Infections Among People Living With HIV Who Are Men Who Have Sex With Men: Efficacy of Serious Game Interventions

National Taiwan University Hospital1 site in 1 country1,320 target enrollmentMarch 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Viral Hepatitis C
Sponsor
National Taiwan University Hospital
Enrollment
1320
Locations
1
Primary Endpoint
HCV incidence
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The study is aimed to provide high-risk, HIV-infection, men who have sex with men (MSM) with healthcare education regarding viral hepatitis C, through either serious game intervention or traditional online health education. After the education, each participants will be followed for 48 weeks and the change of risky sexual behaviors, acquisition of HCV and other STIs will be followed during the study periods.

Detailed Description

High-risk MSM living with HIV were participated in our study will be assigned (by randomization) to either: 1. Serious game intervention: 1 single session of serious game for the participants to play (estimation to take 25-40 minutes). Hepatitis C virus (HCV)-related healthcare informations, including the severity of illness, route of transmission, preventive strategies and treatment options, would be embedded in the game. 2. Traditional online health education (reading materials): 1 single session of healthcare education regarding HCV (with similar contents) will be provided. After the healthcare intervention, each participants will be followed for 48 weeks. Assessment of risky sexual practice (by questionnaire), test of plasma HCV RNA and serological test of syphilis (optional), and detection of sexually-transmitted bacterial pathogens (optional) will be performed at the enrollment and then every 12 weeks during the observation.

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • High-risk MSM living with HIV, defined as:
  • Had prior HCV infection, and had cleared HCV through treatment or spontaneously
  • Had any STI within the past 12 months
  • Had any unexplained elevation of liver transaminase in the past 6 months
  • Had at least 1 unprotected anal sex during the past 6 months
  • Being able to use mobile smartphone and understand study materials
  • Repeat entry of study is permitted, but the interval between health education intervention should \>52 weeks.

Exclusion Criteria

  • HCV RNA positive and yet clear virus (nor reaching SVR12).
  • Admission for any acute illness (including AIDS-defining conditions)

Outcomes

Primary Outcomes

HCV incidence

Time Frame: 48 weeks

The incidence rate of HCV acquisition between both arms. HCV RNA would be tested for each participants every 3 months during follow-up, and the incidence rate is calculated as following: new cases of HCV viremia / person-time of follow-up.

Secondary Outcomes

  • STI incidence(48 weeks)
  • The frequency of condom use and sexualized drug use(At weeks 12, 24 and 48 of observation)

Study Sites (1)

Loading locations...

Similar Trials